Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Nihon Sanka Fujinka Gakkai Zasshi
|
October 1, 1988
[Measurement of Gla proteins by dot method and clinical study (protein S, protein C, and prothrombin)]
A Osaki
International Journal of Oncology
|
May 5, 2011
Relative effects of immunohistochemical expressions of c-erbB-2, p53, and bcl-2 oncoproteins on the survival of advanced breast cancer patients after endocrine therapy
A Osaki, Y Nomura
Current Hypertension Reviews
|
July 5, 2014
Nesfatin/Nucleobindin-2 (NUCB2) and Glucose Homeostasis
H Shimizu, A Osaki
International Journal of Oncology
|
October 18, 2001
A pitfall in the survival benefit of adjuvant chemotherapy for node- and hormone receptor-positive patients with breast cancer: the paradoxical role of Bcl-2 oncoprotein (review)
R Kim, A Osaki, T Toge
Breast Cancer Research and Treatment
|
January 1, 1995
Long term survival and the prognostic factors of advanced breast cancer patients treated with adreno-oophorectomy
Y Nomura, H Tashiro, A Osaki
Journal of Biochemistry
|
March 1, 1994
Dissociation of dimer of bovine erythrocyte Cu,Zn-superoxide dismutase and activity of the monomer subunit: effects of urea, temperature, and enzyme concentration
K Inouye, A Osaki, B Tonomura
Oncology
|
September 1, 1995
A multivariate analysis of prognostic factors including tumor response after endocrine therapy in advanced breast cancer patients
Y Nomura, H Tashiro, A Osaki
Nutrition & Diabetes
|
March 8, 2016
Transgenic mice overexpressing nesfatin/nucleobindin-2 are susceptible to high-fat diet-induced obesity
H Shimizu, M Tanaka, A Osaki
Oncology Reports
|
August 10, 2001
Pharmacokinetic and biochemical analysis in the treatment of weekly paclitaxel in relapsed breast cancer
R Kim, A Osaki, T Toge
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Epidermal growth factor receptor expression as a prognostic indicator in breast cancer
M Toi, A Osaki, H Yamada, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Nihon Sanka Fujinka Gakkai Zasshi
|
October 1, 1988
[Measurement of Gla proteins by dot method and clinical study (protein S, protein C, and prothrombin)]
A Osaki
International Journal of Oncology
|
May 5, 2011
Relative effects of immunohistochemical expressions of c-erbB-2, p53, and bcl-2 oncoproteins on the survival of advanced breast cancer patients after endocrine therapy
A Osaki, Y Nomura
Current Hypertension Reviews
|
July 5, 2014
Nesfatin/Nucleobindin-2 (NUCB2) and Glucose Homeostasis
H Shimizu, A Osaki
International Journal of Oncology
|
October 18, 2001
A pitfall in the survival benefit of adjuvant chemotherapy for node- and hormone receptor-positive patients with breast cancer: the paradoxical role of Bcl-2 oncoprotein (review)
R Kim, A Osaki, T Toge
Breast Cancer Research and Treatment
|
January 1, 1995
Long term survival and the prognostic factors of advanced breast cancer patients treated with adreno-oophorectomy
Y Nomura, H Tashiro, A Osaki
Journal of Biochemistry
|
March 1, 1994
Dissociation of dimer of bovine erythrocyte Cu,Zn-superoxide dismutase and activity of the monomer subunit: effects of urea, temperature, and enzyme concentration
K Inouye, A Osaki, B Tonomura
Oncology
|
September 1, 1995
A multivariate analysis of prognostic factors including tumor response after endocrine therapy in advanced breast cancer patients
Y Nomura, H Tashiro, A Osaki
Nutrition & Diabetes
|
March 8, 2016
Transgenic mice overexpressing nesfatin/nucleobindin-2 are susceptible to high-fat diet-induced obesity
H Shimizu, M Tanaka, A Osaki
Oncology Reports
|
August 10, 2001
Pharmacokinetic and biochemical analysis in the treatment of weekly paclitaxel in relapsed breast cancer
R Kim, A Osaki, T Toge
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Epidermal growth factor receptor expression as a prognostic indicator in breast cancer
M Toi, A Osaki, H Yamada, et al.
Page
of 3